Your browser doesn't support javascript.
loading
CAR T cells: engineered immune cells to treat brain cancers and beyond.
Huang, Zoufang; Dewanjee, Saikat; Chakraborty, Pratik; Jha, Niraj Kumar; Dey, Abhijit; Gangopadhyay, Moumita; Chen, Xuan-Yu; Wang, Jian; Jha, Saurabh Kumar.
Afiliación
  • Huang Z; Department of Hematology, Ganzhou Key Laboratory of Hematology, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
  • Dewanjee S; Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.
  • Chakraborty P; Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India.
  • Jha NK; Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, Uttar Pradesh, 201310, India.
  • Dey A; Department of Life Sciences, Presidency University, 86/1 College Street, Kolkata, West Bengal, 700032, India.
  • Gangopadhyay M; Department of Biotechnology, School of Life Science and Biotechnology, Adamas University, Barasat, Kolkata, West Bengal, 700126, India.
  • Chen XY; Institute for Biotechnology, St. John's University, Queens, New York, 11439, USA.
  • Wang J; Department of Radiotherapy, the Affiliated Jiangyin People's Hospital of Nantong University, Jiangyin, 214400, China. 1627879372@qq.com.
  • Jha SK; Department of Biotechnology, School of Engineering & Technology, Sharda University, Greater Noida, Uttar Pradesh, 201310, India. saurabh.jha@sharda.ac.in.
Mol Cancer ; 22(1): 22, 2023 01 31.
Article en En | MEDLINE | ID: mdl-36721153

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Inmunoterapia Adoptiva Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Inmunoterapia Adoptiva Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Mol Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China